Literature DB >> 18470728

Syndecan-1 - A new piece in B-cell puzzle.

L Kopper1, A Sebestyén, M Gallai, I Kovalszky.   

Abstract

Syndecans are transmembrane proteoglycans, with core proteins mainly decorated with heparan sulfate chains. Syndecan-1 is expressed in a tissue-, cell-and differentiation-specific manner. Its extra-cellular domain can bind via HS chains to matrix elements, to growth factors (especially "heparin-binding" proteins) and to certain biological agents. The ectodomain released by proteolysis can also be functionally active. The cytoplasmic domain can take part in signaling processes as well as in modifying cell shape. In hematopoietic cells syndecan-1 is expressed in normal pre-B-cells and plasma cells, as well as in plasmocytoid and lymphoplasmocytoid malignancies. According to our study syndecan-1 is expressed in B-CLL cells both in tissue environment and in circulation.

Entities:  

Year:  1997        PMID: 18470728     DOI: 10.1007/BF02899919

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  109 in total

Review 1.  Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.

Authors:  M Bernfield; R Kokenyesi; M Kato; M T Hinkes; J Spring; R L Gallo; E J Lose
Journal:  Annu Rev Cell Biol       Date:  1992

Review 2.  Hierarchical organization of hematopoietic microenvironments: role of proteoglycans.

Authors:  A Keating; M Y Gordon
Journal:  Leukemia       Date:  1988-11       Impact factor: 11.528

3.  Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.

Authors:  R E George; R M Kenyon; A G McGuckin; A J Malcolm; A D Pearson; J Lunec
Journal:  Oncogene       Date:  1996-04-04       Impact factor: 9.867

4.  A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.

Authors:  J Wijdenes; W C Vooijs; C Clément; J Post; F Morard; N Vita; P Laurent; R X Sun; B Klein; J M Dore
Journal:  Br J Haematol       Date:  1996-08       Impact factor: 6.998

5.  Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells.

Authors:  M J Stanley; B F Liebersbach; W Liu; D J Anhalt; R D Sanderson
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

6.  Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation.

Authors:  P Inki; F Stenbäck; L Talve; M Jalkanen
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

7.  Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.

Authors:  T B Sneed; D J Stanley; L A Young; R D Sanderson
Journal:  Cell Immunol       Date:  1994-02       Impact factor: 4.868

8.  Aggregation-induced association of syndecan-1 with microfilaments mediated by the cytoplasmic domain.

Authors:  D J Carey; R C Stahl; B Tucker; K A Bendt; G Cizmeci-Smith
Journal:  Exp Cell Res       Date:  1994-09       Impact factor: 3.905

9.  Developmental expression of syndecan, an integral membrane proteoglycan, correlates with cell differentiation.

Authors:  M S Trautman; J Kimelman; M Bernfield
Journal:  Development       Date:  1991-01       Impact factor: 6.868

10.  Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells.

Authors:  C S Lebakken; A C Rapraeger
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

View more
  2 in total

1.  Relapsing Tubulointerstitial Nephritis with Antimitochondrial M2 Antibody Accompanied by Pulmonary Involvement.

Authors:  Aya Nakamori; Fuyuko Akagaki; Yoshito Yamaguchi; Toshihiro Sugiura
Journal:  Intern Med       Date:  2020-02-12       Impact factor: 1.271

2.  Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.

Authors:  Alexandra Y Tsidulko; Liudmila Matskova; Lidiia A Astakhova; Ingemar Ernberg; Elvira V Grigorieva
Journal:  Oncotarget       Date:  2015-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.